Impact of Letrozole on Mature Follicle Rate in Treatment of Subfertility Due to Polycystic Ovarian Syndrome
Letrozole and Follicle Rate in Polycystic Ovarian Syndrome
DOI:
https://doi.org/10.54393/pjhs.v5i08.1878Keywords:
Letrozole, Mature Follicles, Polycystic Ovarian Syndrome, Aromatase InhibitorAbstract
Letrozole was an aromatase inhibitor that has gained prominence as an alternative to the clomiphene citrate for ovulation induction in females with Polycystic Ovarian Syndrome (PCOS). Objective: To assess the frequency of mature follicle rate as a result of letrozole treatment in subfertility due to PCOS. Methods: This interventional study was performed at Obstetrics and Gynecology Department, Combined Military Hospital, Multan, over a period of 6 months, from March 1, 2023 to September 1, 2023. The study included 322 cases aged between 20–40 years, who reported infertility for longer than a year, had Body Mass Index (BMI) <28, and had subfertility due to PCOS. All study participants were subjected to letrozole treatment. Development of mature follicles was observed utilizing transvaginal ultrasound starting from the 10th day of treatment. Results: The mean age of patients was 32.82 ± 4.30 years. The mean weight was 61.74 ± 7.35 kg, whereas the mean height was 1.61 ± 0.069 m. The mean BMI was 23.68 ± 2.96 kg/m². Among the participants, 161 (50.0%) patients had primary infertility, and 161 (50.0%) had secondary infertility. After receiving letrozole treatment, 237 (73.6%) patients had mature follicles on ultrasonography. Conclusions: Letrozole seems to improve the rate of follicle maturation in women with subfertility due to PCOS, thereby increasing the likelihood of pregnancy. Based on these findings, letrozole can be regarded as a suitable alternative to first-line therapies such as clomiphene citrate, providing favorable outcomes and minimal side effects, specifically in patients with clomiphene citrate resistance.
References
Azhar A, Abid F, Rehman R. Polycystic ovary syndrome, subfertility and vitamin D deficiency. Journal of the College of Physicians and Surgeons--Pakistan: Journal of College of Physicians and Surgeons Pakistan. 2020 May; 30(5): 545. doi: 10.29271/jcpsp.2020.05.545. DOI: https://doi.org/10.29271/jcpsp.2020.05.545
Anjum S, Askari S, Riaz M, Basit A. Clinical presentation and frequency of metabolic syndrome in women with polycystic ovary syndrome: An experience from a tertiary care hospital in Pakistan. Cureus. 2020 Dec; 12(12): e11860. doi: 10.7759/cureus.11860. DOI: https://doi.org/10.7759/cureus.11860
Jadoon H, Islam A, Rehman S, Gul M, Bibi M, Fakhar H. Polycystic Ovarian Syndrome Prevalence in Adult Unmarried Females Visiting a Territory Care Hospital. Journal of The Society of Obstetricians and Gynaecologists of Pakistan. 2023 Sep; 13(3): 277-83.
Abu-Zaid A, Gari A, Sabban H, Alshahrani MS, Khadawardi K, Badghish E et al. Comparison of Letrozole and Clomiphene Citrate in Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. Reproductive Sciences. 2024 Apr; 31(4): 883-905. doi: 10.1007/s43032-023-01404-8. DOI: https://doi.org/10.1007/s43032-023-01404-8
Chang KJ, Chen JH, Chen KH. The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature. International Journal of Molecular Sciences. 2024 Aug; 25(16): 9037. doi: 10.3390/ijms25169037. DOI: https://doi.org/10.3390/ijms25169037
Panda SR, Sharmila V, Kalidoss VK, Hota S. A triple‐blind, randomized controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndrome. International Journal of Gynecology & Obstetrics. 2023 Apr; 161(1): 63-70. doi: 10.1002/ijgo.14476. DOI: https://doi.org/10.1002/ijgo.14476
Rababa’h AM, Matani BR, Yehya A. An update of polycystic ovary syndrome: causes and therapeutics options. Heliyon. 2022 Oct; 8(10). doi: 10.1016/j.heliyon.2022.e11010. DOI: https://doi.org/10.1016/j.heliyon.2022.e11010
Mitwally MF and Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility and Sterility. 2001 Feb; 75(2): 305-9. doi: 10.1016/S0015-0282(00)01705-2. DOI: https://doi.org/10.1016/S0015-0282(00)01705-2
Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertility and Sterility. 2019 Mar; 111(3): 571-8. doi: 10.1016/j.fertnstert.2018.11.030. DOI: https://doi.org/10.1016/j.fertnstert.2018.11.030
Sakar MN and Oglak SC. Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome. Pakistan Journal of Medical Sciences. 2020 Nov; 36(7): 1460. doi: 10.12669/pjms.36.7.3345. DOI: https://doi.org/10.12669/pjms.36.7.3345
Wasim T, Nasrin T, Zunair J, Irshad S. Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome. Pakistan Journal of Medical Sciences. 2024 Jan; 40(1Part-I): 78. doi: 10.12669/pjms.40.1.7971. DOI: https://doi.org/10.12669/pjms.40.1.7971
Ali SM, ABDULHUSSEIN IF, Kazom SN. Comparison of Letrozole vs Clomiphene Citrate for induction of ovulation in polycystic ovarian syndromeAn Iraqi study. Texas Journal of Medical Science. 2024 Mar; 30: 23-39. doi: 10.62480/tjms.2024.vol30.pp23-39. DOI: https://doi.org/10.62480/tjms.2024.vol30.pp23-39
Pundir J, Achilli C, Bhide P, Sabatini L, Legro RS, Rombauts L et al. Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis. Human Reproduction Update. 2021 May; 27(3): 474-85. doi: 10.1093/humupd/dmaa055. DOI: https://doi.org/10.1093/humupd/dmaa055
Elkhalifa WS, Suliman HM, Abdoon IH, Mohamed W, Osman B. Letrozole vs clomiphene citrate in Sudanese patients with infertility secondary to polycystic ovary syndrome. Heliyon. 2023 Jul; 9(7). doi: 10.1016/j.heliyon.2023.e18107. DOI: https://doi.org/10.1016/j.heliyon.2023.e18107
Franik S, Le QK, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2022 Sep; 9 (9): CD010287. doi: 10.1002/14651858.CD010287.pub4. DOI: https://doi.org/10.1002/14651858.CD010287.pub4
Desai PB, Karve AS, Zawit M, Arora P, Dave N, Awosika J et al. A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas. Clinical Cancer Research. 2024 May; 30(10): 2068-77. doi: 10.1158/1078-0432.CCR-23-3341. DOI: https://doi.org/10.1158/1078-0432.CCR-23-3341
Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones. 2021 Sep; 20(3): 449-61. doi: 10.1007/s42000-021-00289-z. DOI: https://doi.org/10.1007/s42000-021-00289-z
Bansal S, Goyal M, Sharma C, Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: A randomized controlled trial. International Journal of Gynecology & Obstetrics. 2021 Mar; 152(3): 345-50. doi: 10.1002/ijgo.13375. DOI: https://doi.org/10.1002/ijgo.13375
Al-Shaikh SF, Al-Mukhatar EJ, Al-Zubaidy AA, Al-Rubaie BJ, Al-Khuzaee L. Use of clomiphene or letrozole for treating women with polycystic ovary syndrome related subfertility in Hilla city. Middle East Fertility Society Journal. 2017 Jun; 22(2): 105-10. doi: 10.1016/j.mefs.2016.12.003. DOI: https://doi.org/10.1016/j.mefs.2016.12.003
Wang R and Mol BW. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Human Reproduction. 2017 Feb; 32(2): 261-4. doi: 10.1093/humrep/dew287. DOI: https://doi.org/10.1093/humrep/dew287
Mohsin RA, Saeed AS, Baig MM, Khan M. Role of letrozole and metformin vs letrozole alone in ovulation induction in patients of polycystic ovarian syndrome. Journal The Pakistan Journal of Medical & Health Sciences. 2019 Jan-Mar; 13(1): 350-2.
Delvigne A. Letrozole or Clomiphene citrate to treat anovulatory PCOS. Médecine De La Reproduction. 2024 Jan; 26(1): 19-29. doi: 10.1684/mte.2024.0988. DOI: https://doi.org/10.1684/mte.2024.0988
Hegde R and Maitra C. Comparison of the role of letrozole & clomiphene citrate as a first line ovulation induction drug in infertile women with polycystic ovary syndrome. Indian J Obstet Gynecol Res. 2020 Feb; 7(1): 12-5. doi: 10.18231/j.ijogr.2020.003. DOI: https://doi.org/10.18231/j.ijogr.2020.003
Javeria M, Qayyum N, Hanif QU, Hussain S, Majeed S, Azam M. Role of Clomiphene Citrate Treatment in Subfertility Due to Polycystic Ovarian Syndrome. Journal of The Society of Obstetricians and Gynaecologists of Pakistan. 2024 Jun; 14(2): 109-12.
Gupta E, Nayar K, Singh M, Gupta S, Bhattacharya RJFS, Research. To study the comparison of efficacy of letrozole versus clomiphene citrate for ovulation induction in infertile women with PCOS in Indian population. 2020 Jul-Dec; 7(2): 162. doi: 10.4103/fsr.fsr_23_20. DOI: https://doi.org/10.4103/fsr.fsr_23_20
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
